Noradrenergic signaling controls Alzheimer's disease pathology via activation of microglial β2 adrenergic receptors
Linh Le, Alexis M. Feidler, Leticia Rodrı́guez, MaKenna Y. Cealie, Elizabeth C. Plunk, Herman Li, Kallam Kara-Pabani, Cassandra E. Lamantia, M. Kerry O’Banion, Ania Katarzyna Majewska
This study shows that microglial β2 adrenergic receptors modulate Alzheimer's disease pathology by reducing inflammation and amyloid pathology in mouse models.
bioRxiv · Dec 1, 2023Neuroscience